PROFICIENT STRIDES AND INHERENT LIMITATIONS IN CURRENT DIAGNOSTIC STRATEGY OF BREAST MASS

Abstract

Breast masses might be a mass discovered by patients incidentally during breast self-examination or else by the physician during routine physical examination. These masses have a variable etiology and nature. while, Fibroadenoma considered the most common benign breast mass, contrary, invasive ductal carcinoma is the most common malignancy [1]. Although, the vast majority of these masses are benign, still breast cancer is the furthermost frequently resulting malignancy in females worldwide having an age-standardized incidence rate (ASR) of 39.0 per 100,000 females, and the second leading cause of cancer deaths in women [2-4]. In spite of most breast cancers occur in women older than 50 years, one third of women diagnosed with breast cancer between 1996 and 2000 were younger than 50 years [5,6]. Contempt of medical advances and assuring treatment regime, morbidity and mortality due to breast cancer has seen no signicant changes in developing countries. In the US in 2020, estimations reach 276,480 new cases of invasive breast cancer in women ,and an additional 48,530 cases of ductal carcinoma in situ diagnosed in women [7]. Also, an estimated mortality of 42,170 female patients with breast cancer will occur in 2020. Invasive female breast cancer incidence rates trends increased slightly, by 0.3% per year [2,6,8]. This might probably be due to lack of systematic screening and early detection